Yuhan, KMSI joins hands for new drug R&D projects

Published: 2007-05-28 06:56:00

Updated: 2007-05-28 06:56:00

Yuhan Corporation signed a memorandum of understanding on May 22 with KMSI, a biopharmaceutical company, to conduct a joint collaboration for developing and commercializing new natural drugs and health foods.

Established by professors and clinicians involved in Western and Oriental medicine in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK